Company Filing History:
Years Active: 2017-2019
Title: Hiromichi Sawaki: Innovator in Cancer Diagnosis
Introduction
Hiromichi Sawaki is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of cancer diagnostics, particularly focusing on epithelial ovarian cancer. With a total of two patents to his name, his work is aimed at improving the detection and diagnosis of this serious condition.
Latest Patents
Sawaki's latest patents include an antibody for detecting an epithelial ovarian cancer marker and a method for diagnosing epithelial ovarian cancer. The first patent provides an antibody capable of specifically recognizing and detecting a highly specific epithelial ovarian cancer marker. This invention includes an anti-β1,6-N-acetylglucosaminyltransferase 5B antibody, which is designed for the diagnosis of epithelial ovarian cancer. The antibody recognizes a part of a polypeptide of the enzyme consisting of a specific amino acid sequence. The second patent also focuses on an antibody for detecting another glycosyltransferase, β1,3-N-acetylglucosaminyltransferase 3, as an epithelial ovarian cancer marker. This invention aims to provide a highly specific cancer marker for effective diagnosis.
Career Highlights
Hiromichi Sawaki is affiliated with the National Institute of Advanced Industrial Science and Technology. His work at this esteemed institution has allowed him to focus on innovative research in cancer diagnostics. His contributions have the potential to significantly impact the early detection and treatment of ovarian cancer.
Collaborations
Some of his notable coworkers include Maki Sogabe and Tomomi Kubota. Their collaborative efforts in research have further advanced the field of cancer diagnostics.
Conclusion
Hiromichi Sawaki's innovative work in developing antibodies for cancer detection showcases his commitment to improving medical diagnostics. His patents represent a significant step forward in the fight against epithelial ovarian cancer.